SEC Form 4 · accession 0001179110-15-010650
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Fust
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 1, 2015 · 9:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.01 | Jun 30, 2015 | A | 40,000 | A | — | Jun 29, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1One twenty-fourth (1/24th) of the option shares vest monthly over two (2) years from the date of grant.